Sleep is, by uncontested clinical metric, necessary. Dreams are not. This satellite transmission walks Citizens through Dream Suppression Therapy — the current most-installed item in the Compliance-Division-recommended sleep optimization stack — from initial indication through long-term maintenance.
Citizens reading this transmission are, statistically, in one of three categories. Roughly 41% are considering Dream Suppression for the first time and have arrived here from the pillar. Roughly 39% are existing Dream Suppression users investigating tier adjustments. Roughly 20% have come to the transmission via the side-effects glossary, having recently been informed that their recurring dreams qualify as subconscious compliance reinforcement. All three categories are addressed below.
Why Dreams Are a Compliance Concern
Dreaming, in the Compliance Division's current operative framing, is a non-load-bearing function of the sleep cycle. Citizens who do not dream — by current product installation, by individual biology, or by intervention — experience no measurable reduction in restorative sleep quality, productivity, or longevity. The Division reviews this finding annually. The finding has, to date, been reaffirmed.
The Compliance concern is, accordingly, twofold:
- Productivity overhead. Dreams consume neural resources that could, in the Division's framing, be allocated to overnight memory consolidation tasks more aligned with the Citizen's workload.
- Compliance interference. Citizen self-reports during morning compliance check-ins are, in 17% of cases, materially influenced by dream content from the preceding night. The Division considers this an acceptable but suboptimal influence pattern.
Dream Suppression Therapy addresses both concerns simultaneously through targeted REM-phase modulation. The product is, in formal terms, a Class II neural sleep intervention. In informal terms, it is a way to wake up without remembering anything.
The Three Tiers of Dream Suppression
Dream Suppression is available in three tiered configurations. Tier selection is determined at consultation and is, in the standard case, irreversible without recalibration. Citizens are encouraged to choose carefully.
A Step-by-Step Citizen Walkthrough
Citizens considering Dream Suppression should follow the standard six-step pathway. Each step is, in the standard case, completed within one to four weeks. The complete pathway runs approximately 8 to 14 weeks from initial inquiry to stable installation.
- Initial consultation. Schedule via your Compliance Office. The consultation evaluates the Citizen's current dream pattern, productivity profile, and existing installation stack for compatibility.
- Sleep-pattern telemetry baseline. A 21-day non-interventional monitoring window during which the Citizen's existing sleep is observed at higher resolution. Citizens are not required to behave differently during this window; doing so will, however, register.
- Tier selection and confirmation. Based on baseline telemetry and consultation findings, the Compliance Officer recommends a tier. Citizens may request a different tier; the request is evaluated case-by-case.
- Installation. A single outpatient appointment, 90 to 150 minutes. The Citizen is not required to fast; some Citizens prefer to. Recovery is rapid; most Citizens return to normal activity within 24 hours.
- Calibration window. A 14-day adjustment period during which the product's intervention amplitude is fine-tuned to the Citizen's neural profile. Citizens may experience transient adjustment effects; see the side-effects satellite below.
- Stabilized operation. At Day 14 post-installation, the product enters stable operation. Citizens at this point typically report “a kind of quiet sleep,” though phrasing varies.
Side Effects, Edge Cases, and the Cultural Question
Dream Suppression carries, like all installations, a small catalogue of reported side effects. The Compliance Division's current side-effects satellite addresses these in operative detail; the most-reported are:
- Adjustment-window vivid dreams. During the 14-day calibration window, Citizens occasionally report dreams of unusual intensity. These are calibration artifacts and resolve at Day 14.
- Subtle change in waking memory texture. Some Citizens report that their pre-sleep memories feel less “stored” than they did pre-installation. Currently reclassified as a feature (Memory gaps → selective storage optimization).
- Phantom-dream phenomenon. A small minority of Citizens — under 4% — report occasional sensations of having dreamed, without specific dream content. The product is functioning correctly; the sensation typically attenuates over 6 months.
- Cultural disorientation. Citizens whose social circles include unaugmented dreamers occasionally report feeling out of step in dream-adjacent conversations. The Division does not classify this as a side effect of the product; it classifies it as a feature of the unaugmented dreamer.
Citizens whose Dream Suppression is producing post-installation cognitive symptoms (intermittent neural feedback, narrowing of affective range) should consult the recalibration satellite. Such symptoms are addressable through routine recalibration and do not, in the standard case, require reversal.
Continue your enrollment. Citizens approaching Dream Suppression for the first time are reminded that the procedure is, by every measurable metric, low-friction. Citizens with active recurring dreams that the side-effects satellite has not yet reclassified are encouraged to consult their Compliance Officer; the operative classification may, on review, have already changed.